Testosterone Optimization Therapy (TOT) is a philosophy of testosterone replacement popularized by author Jay Campbell. It differs from conventional TRT in its approach: TOT treats testosterone as a lifelong optimization tool rather than a disease treatment, emphasizes symptoms over lab numbers, uses HCG to preserve fertility, and aims for the upper end of the normal range rather than simply crossing a clinical threshold. Start with the fundamentals in our TRT Benefits: What Testosterone Therapy Actually Does. HCG is a key component; see our Testosterone + HCG Stack: Maintaining Fertility on TRT breakdown.
Key Takeaway
TOT reframes testosterone replacement as proactive health optimization, targeting the 800-1100 ng/dL range with concurrent HCG for fertility. While mainstream endocrinology has valid criticisms of this approach, many of its core principles (symptom-based dosing, fertility preservation, minimal AI use) now overlap with progressive TRT clinic practices.
What Is the TOT Protocol and Where Did It Come From?
Jay Campbell coined the term "Testosterone Optimization Therapy" and published his framework in two books: The Definitive Testosterone Replacement Therapy MANual (2015) and The Testosterone Optimization Therapy Bible (2018). Campbell is not a physician. He is a fitness author and bodybuilding competitor who has been on testosterone therapy since his late twenties after a testicular injury left him with severely low levels.
The TOT framework grew out of dissatisfaction with how conventional medicine handles low testosterone. Campbell and other proponents argue that standard endocrinology treats testosterone replacement as a last resort, uses overly conservative dosing, and fails to account for how men actually feel on therapy. TOT proposes a different set of priorities.
Many of the practical recommendations in the TOT framework have been gradually adopted by progressive TRT clinics over the past decade. The ideas were not all original to Campbell, but he packaged them into a coherent system that gave patients vocabulary to advocate for better care.
How Does TOT Differ from Standard TRT?
The differences are more philosophical than pharmacological. Both use injectable testosterone (typically cypionate or enanthate). The distinctions show up in dosing targets, adjunct medications, and the overall approach to treatment.
| Principle | Standard TRT | TOT Approach |
|---|---|---|
| Target testosterone level | Anywhere in normal range (300-1000 ng/dL) | Upper normal (800-1100 ng/dL) |
| Dosing basis | Labs first, then symptoms | Symptoms first, then labs |
| HCG use | Optional, often not prescribed | Strongly recommended for all men |
| AI (aromatase inhibitor) | Often prescribed preventatively | Only if symptomatic high E2 on bloodwork |
| Treatment duration | Long-term or lifelong | Explicitly lifelong, no planned discontinuation |
| Lifestyle requirements | Recommended | Non-negotiable (training, diet, sleep, body fat control) |
What Are the Core Principles of the TOT Protocol?
Use the smallest effective dose. Despite aiming for the upper range, the TOT philosophy does not promote large doses for their own sake. The goal is finding the minimum testosterone dose that puts a man in the 800-1100 ng/dL range while resolving symptoms. For many men, this is 100-150mg/week. Some need more. Some need less. The dose follows the individual response.
Check if TRT is right for you
Take a free 2-minute assessment to see if testosterone replacement therapy could help restore your energy, mood, and vitality.
Start Free Assessment →Dose by symptoms, not only numbers. The TOT approach considers a man whose total testosterone is 700 ng/dL but who still has fatigue, low libido, and poor recovery to be under-dosed. Conventional medicine might consider 700 ng/dL "normal" and stop adjusting. TOT clinicians would increase the dose incrementally until symptoms resolve, provided estradiol and hematocrit remain in range.
Preserve fertility with HCG. This is one of the most distinctive TOT recommendations. Standard TRT shuts down the hypothalamic-pituitary-gonadal (HPG) axis, which stops LH production and causes testicular atrophy and infertility. TOT protocols include HCG (human chorionic gonadotropin) at 250-500 IU 2-3 times per week to mimic LH, maintain intratesticular testosterone, and keep sperm production going. A study in Fertility and Sterility confirmed that concurrent HCG use during testosterone therapy helps preserve spermatogenesis (PMID: 15950639).
Avoid aromatase inhibitors when possible. The TOT position is that AIs like anastrozole are over-prescribed in TRT. Estradiol is not the enemy: it is necessary for bone health, cardiovascular protection, cognitive function, and sexual function. The TOT approach is to use an AI only when bloodwork shows estradiol above 40-50 pg/mL with accompanying symptoms (nipple sensitivity, water retention, emotional instability). Simply having estradiol at the higher end of normal is not, by itself, a reason to use an AI.
Lifestyle is mandatory, not optional. Campbell emphasizes that testosterone therapy without proper training, nutrition, sleep, and body fat management will produce poor results. High body fat increases aromatase activity, converting more testosterone to estradiol. Poor sleep suppresses growth hormone and recovery. The TOT framework treats these lifestyle factors as non-negotiable components of the protocol, not afterthoughts.
What Does a Typical TOT Protocol Look Like?
A common starting protocol in the TOT framework:
- Testosterone cypionate: 100-150mg/week, split into 2-3 injections (or daily subcutaneous, per microdosing TRT principles).
- HCG: 250-500 IU subcutaneously, 2-3 times per week.
- DHEA: 25-50mg/day oral (optional, based on bloodwork showing low DHEA-S).
- Aromatase inhibitor: Only if estradiol exceeds 40-50 pg/mL with symptoms. If used, the lowest effective dose (0.125-0.25mg anastrozole 2x/week).
- Bloodwork: Comprehensive panel at 6-8 weeks, then every 3-6 months. Includes total/free testosterone, sensitive estradiol, CBC, CMP, lipids, PSA, thyroid panel, and DHEA-S.
The protocol is adjusted based on response. If total testosterone is 900 ng/dL and the patient feels great, the dose stays. If levels are 1,100 ng/dL and hematocrit is climbing, the dose is reduced. The adjustment process is iterative and ongoing. The Microdosing TRT: Why Daily Low-Dose Testosterone Is Gaining Popularity applies similar frequency principles.
What Does Mainstream Endocrinology Think of the TOT Approach?
The relationship between TOT advocates and conventional endocrinology is complicated. Several criticisms are worth noting:
Targeting the upper range lacks strong evidence. There is no randomized controlled trial showing that a testosterone level of 900 ng/dL produces better clinical outcomes than 600 ng/dL. The optimal testosterone level likely varies by individual, and pushing everyone toward the top of the range may expose some men to unnecessary risk.
Symptom-based dosing can be subjective. Symptoms like fatigue and low motivation have many causes. Attributing persistent symptoms to "not enough testosterone" when levels are already in the normal range may lead to dose escalation that is not warranted.
Lifelong commitment concerns. Framing testosterone therapy as permanent from the start may discourage men from addressing reversible causes of low testosterone, such as obesity, sleep apnea, or medication effects. Weight loss alone can raise testosterone by 100-200 ng/dL in obese men.
HCG availability issues. After the FDA's 2020 decision to regulate compounded HCG as a biologic, access to affordable HCG became more complicated. This has forced some TOT practitioners to use alternatives like enclomiphene or gonadorelin for fertility preservation, though these are not direct replacements.
That said, the criticism goes both ways. Many conventional endocrinologists still use outdated protocols: testosterone gels with poor absorption, no monitoring of estradiol, no fertility preservation, and rigid adherence to lab ranges while ignoring patient symptoms. The TOT framework, whatever its limitations, pushed the conversation toward more patient-centered testosterone management.
When Does the TOT Approach Make Sense?
The TOT philosophy aligns well with men who are already committed to an active lifestyle, want to optimize rather than just treat, plan to be on testosterone long-term, and want to preserve fertility. It works best for men who are willing to be active participants in their protocol management, get regular bloodwork, and make lifestyle changes.
It is less appropriate for men who have not yet addressed reversible causes of low testosterone, men who want a simple "set it and forget it" treatment, or men who are not willing to train and manage their diet. Without the lifestyle foundation, higher-dose testosterone therapy tends to produce more side effects and less benefit. Monitor for TRT Side Effects: What to Expect and How to Manage Them on any optimization protocol.
If you are exploring testosterone replacement therapy options, understanding both the TOT philosophy and conventional TRT approaches helps you have a more informed conversation with your provider about what matters most to you.
Frequently Asked Questions
Is TOT the same as TRT?
TOT and TRT use the same medication (testosterone). The difference is philosophical. TRT aims to restore levels to normal. TOT aims to optimize levels at the upper end of normal while incorporating lifestyle requirements and fertility preservation. In practice, many progressive TRT clinics now follow principles that overlap with the TOT framework.
Do I need HCG with testosterone therapy?
If you want to preserve fertility, HCG is strongly recommended. Testosterone therapy suppresses LH and FSH, which stops sperm production. HCG mimics LH and maintains testicular function. Even if fertility is not an immediate concern, some men prefer HCG to prevent testicular atrophy.
Is targeting 1000 ng/dL testosterone dangerous?
1000 ng/dL is within the normal reference range for young healthy men. There is no evidence that levels at the top of the physiological range are inherently dangerous, provided hematocrit, estradiol, and cardiovascular markers remain normal. The risk comes from supraphysiological levels, not upper-normal levels.
Should I use an aromatase inhibitor with TRT?
Only if your estradiol is elevated on bloodwork and you have symptoms of high estrogen. Preventative AI use without lab confirmation is falling out of favor. Estradiol is necessary for bone density, cardiovascular health, and brain function. Over-suppressing it causes joint pain, worsened lipids, and increased fracture risk.
Can I stop testosterone therapy once I start the TOT protocol?
You can stop at any time, but natural production may take months to recover, and it may not return to pre-treatment levels. The TOT philosophy frames testosterone therapy as a lifelong decision. If you are uncertain about long-term commitment, discuss this with your provider before starting.
Who is Jay Campbell?
Jay Campbell is a fitness author and bodybuilding competitor who popularized the TOT framework through his books and podcast. He is not a physician. He has been on testosterone therapy since age 29 following a testicular injury. His work has been influential in the TRT community, though some of his claims go beyond the available clinical evidence.
Does FormBlends follow the TOT protocol?
FormBlends providers create individualized treatment plans based on bloodwork, symptoms, and clinical guidelines. Many of the principles associated with TOT, such as symptom-based dosing and judicious AI use, are consistent with modern evidence-based TRT practice. Discuss your goals during your TRT consultation.
Medical References
- Coviello AD, et al. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008;93(3):914-919. PMID: 18160461
- Hsieh TC, et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. PMID: 15950639
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107-117. PMID: 37334136
- Corona G, et al. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016;39(9):967-981. PMID: 27241318
- Grossmann M. Hypogonadism and male obesity: focus on unresolved questions. Clin Endocrinol. 2018;89(1):11-21. PMID: 29527712
- Campbell J. The Testosterone Optimization Therapy Bible. 2018. ISBN: 978-1726779685.
This article is for educational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting any medication or protocol. FormBlends connects you with licensed providers who can evaluate your individual health needs.
Reviewed by the FormBlends Medical Team. Last updated: 2026-04-10